- Q4 2025 revenue decreased by 8% to EUR 663.7 million, with an operative EBITDA margin of 18.1%.
- Kemira completed the acquisition of Water Engineering, Inc. in October and announced the acquisition of AquaBlue, Inc. in early 2026.
- A new share buyback program of up to 5,000,000 shares or EUR 100 million is proposed.
- Kemira plans to continue investments in growth, including the acquisition of SIDRA Wasserchemie.
Q4 2025 Performance
Revenue decreased by 8% to EUR 663.7 million, with declines across all business units due to market softness and FX impact. Operative EBITDA fell by 11% to EUR 119.9 million, with a margin of 18.1%. Items affecting comparability within EBITDA totaled EUR 32.4 million, mainly due to restructuring and streamlining costs.
Full Year 2025 Performance
For January-December 2025, revenue decreased by 5% to EUR 2,753.5 million. Operative EBITDA decreased by 10% to EUR 524.6 million, driven by pricing and lower sales volumes. The operative EBIT decreased by 18% to EUR 324.4 million.
Strategic Moves
Kemira completed the acquisition of Water Engineering, Inc. in October, expanding its Water Solutions business into industrial water treatment services. The integration work is ongoing, and the acquisition of AquaBlue, Inc. was announced at the beginning of 2026. Further acquisitions are expected in the coming quarters.
Financial Outlook and Initiatives
For 2026, Kemira expects revenue between EUR 2,600 million and EUR 3,000 million, with operative EBITDA between EUR 470 million and EUR 570 million. A new share buyback program of up to 5,000,000 shares or EUR 100 million is proposed to optimize capital structure. The company continues to invest in growth, including the acquisition of SIDRA Wasserchemie and capacity expansions in coagulant and active carbon reactivation.
